Castle Biosciences Inc (CSTL)

32.72 +0.55 (+1.71%) USD  |  NASDAQ  |  Jan 08, 16:00
32.74 +0.02 (+0.06%) After-Hours: 20:00
More

Castle Biosciences Total Long Term Debt (Quarterly): 10.02M for Sept. 30, 2024

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for CSTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Delcath Systems Inc 2.00M
CytoSorbents Corp 13.81M
CytomX Therapeutics Inc 0.00
Spero Therapeutics Inc 0.00
Progyny Inc 0.00